IQVIA (NYSE:IQV) Releases FY24 Earnings Guidance

IQVIA (NYSE:IQV) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $11.10-11.20 for the period, compared to the consensus EPS estimate of $11.19. The company issued revenue guidance of $15.35-15.40 billion, compared to the consensus revenue estimate of $15.46 billion. IQVIA also updated its FY 2024 guidance to 11.100-11.200 EPS.

Analyst Ratings Changes

IQV has been the topic of a number of research analyst reports. StockNews.com raised IQVIA from a “hold” rating to a “buy” rating in a research note on Wednesday. Robert W. Baird increased their price target on shares of IQVIA from $251.00 to $256.00 and gave the stock a “neutral” rating in a research note on Friday, September 20th. Argus upgraded IQVIA to a “strong-buy” rating in a report on Wednesday, July 31st. Evercore ISI dropped their price target on IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, Barclays reduced their price objective on IQVIA from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 15th. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $267.27.

IQVIA Price Performance

IQV stock opened at $199.00 on Thursday. The company has a market capitalization of $36.28 billion, a PE ratio of 28.06, a P/E/G ratio of 2.09 and a beta of 1.49. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 1.80. The stock’s 50 day moving average is $235.88 and its two-hundred day moving average is $230.06. IQVIA has a 52-week low of $167.42 and a 52-week high of $261.73.

Insiders Place Their Bets

In related news, insider Eric Sherbet sold 1,300 shares of the business’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the sale, the insider now directly owns 19,536 shares of the company’s stock, valued at $4,812,302.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by company insiders.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.